Published in Infect Immun on April 29, 2013
Vibrio cholerae evades neutrophil extracellular traps by the activity of two extracellular nucleases. PLoS Pathog (2013) 1.07
Proteomic analysis of Vibrio cholerae outer membrane vesicles. Proc Natl Acad Sci U S A (2014) 1.06
Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles. Int J Med Microbiol (2013) 0.89
A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles. Front Microbiol (2015) 0.89
Characterization of the Vibrio cholerae extracellular matrix: a top-down solid-state NMR approach. Biochim Biophys Acta (2014) 0.86
Antibacterial activity of silver and zinc nanoparticles against Vibrio cholerae and enterotoxic Escherichia coli. Int J Med Microbiol (2014) 0.84
Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology. Infect Immun (2015) 0.84
Host-like carbohydrates promote bloodstream survival of Vibrio vulnificus in vivo. Infect Immun (2015) 0.80
A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice. PLoS Negl Trop Dis (2015) 0.80
Bottom-up and top-down solid-state NMR approaches for bacterial biofilm matrix composition. J Magn Reson (2015) 0.77
Immunizing adult female mice with a TcpA-A2-CTB chimera provides a high level of protection for their pups in the infant mouse model of cholera. PLoS Negl Trop Dis (2014) 0.76
O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh. Clin Vaccine Immunol (2016) 0.75
Immunity Provided by an Outer Membrane Vesicle Cholera Vaccine is Due to O-Antigen-Specific Antibodies Inhibiting Bacterial Motility. Infect Immun (2016) 0.75
Meningococcal Outer Membrane Vesicle Composition-Dependent Activation of the Innate Immune Response. Infect Immun (2016) 0.75
A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem (1957) 173.99
Studies on transformation of Escherichia coli with plasmids. J Mol Biol (1983) 116.81
Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol (1995) 46.37
Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem (1996) 45.70
A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem (1982) 36.39
A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol (1988) 31.85
Lipopolysaccharide endotoxins. Annu Rev Biochem (2001) 18.88
WHO estimates of the causes of death in children. Lancet (2005) 18.33
Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect Immun (1991) 15.39
Cholera. Clin Microbiol Rev (1995) 12.33
Cholera. Lancet (2004) 10.22
Adhesive properties of Vibrio cholerae: nature of the interaction with intact mucosal surfaces. Infect Immun (1976) 5.36
Cholera vaccines: WHO position paper. Wkly Epidemiol Rec (2010) 5.24
Field trial of a locally produced, killed, oral cholera vaccine in Vietnam. Lancet (1997) 4.56
Culture conditions for stimulating cholera toxin production by Vibrio cholerae O1 El Tor. Microbiol Immunol (1986) 4.38
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vivo studies. Infect Immun (1981) 4.34
Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu Rev Microbiol (2010) 4.13
Cholera. Lancet (2012) 3.80
The true burden and risk of cholera: implications for prevention and control. Lancet Infect Dis (2007) 3.61
Selection for in vivo regulators of bacterial virulence. Proc Natl Acad Sci U S A (2001) 2.98
A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide. J Clin Invest (1996) 2.94
Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid. Infect Immun (1976) 2.92
Identification of toxS, a regulatory gene whose product enhances toxR-mediated activation of the cholera toxin promoter. J Bacteriol (1989) 2.87
Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype. J Infect Dis (1994) 2.67
New medium for the production of cholera toxin by Vibrio cholerae O1 biotype El Tor. J Clin Microbiol (1985) 2.43
Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype. Lancet (1995) 2.43
AN ELECTRON MICROSCOPE STUDY OF VIBRIO FLAGELLA. J Gen Microbiol (1963) 2.40
MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain. Vaccine (2005) 2.20
Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity. Infect Immun (2001) 2.16
Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann (1991) 2.13
Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge. J Infect Dis (1995) 2.10
Live attenuated oral cholera vaccines. Expert Rev Vaccines (2006) 2.07
The activity of a putative polyisoprenol-linked sugar translocase (Wzx) involved in Escherichia coli O antigen assembly is independent of the chemical structure of the O repeat. J Biol Chem (1999) 2.06
Thymus-independent and thymus-dependent responses to polysaccharide antigens. J Infect Dis (1992) 1.98
Antibodies directed against the toxin-coregulated pilus isolated from Vibrio cholerae provide protection in the infant mouse experimental cholera model. J Infect Dis (1990) 1.97
Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine (2009) 1.88
Lipopolysaccharides of Vibrio cholerae. I. Physical and chemical characterization. Biochim Biophys Acta (2003) 1.86
Amino acid addition to Vibrio cholerae LPS establishes a link between surface remodeling in gram-positive and gram-negative bacteria. Proc Natl Acad Sci U S A (2012) 1.83
Cholera outbreak --- Haiti, October 2010. MMWR Morb Mortal Wkly Rep (2010) 1.77
Molecular basis of reduced potency of underacylated endotoxins. J Immunol (2005) 1.77
Mucosal penetration primes Vibrio cholerae for host colonization by repressing quorum sensing. Proc Natl Acad Sci U S A (2008) 1.63
Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity. Int Arch Allergy Appl Immunol (1975) 1.56
Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice. Infect Immun (2008) 1.50
Significance of toxin-coregulated pili as protective antigens of Vibrio cholerae in the infant mouse model. Vaccine (1989) 1.50
Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers. Vaccine (1992) 1.49
Quantification of bacterial lipopolysaccharides by the purpald assay: measuring formaldehyde generated from 2-keto-3-deoxyoctonate and heptose at the inner core by periodate oxidation. Anal Biochem (1999) 1.46
Infectious diseases. Haiti's outbreak is latest in cholera's new global assault. Science (2010) 1.45
Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin. Infect Immun (1992) 1.45
Enteric infections and the vaccines to counter them: future directions. Vaccine (2006) 1.45
A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via toll-like receptor (TLR) 2 but not via TLR4/MD2. J Infect Dis (2000) 1.38
Wzx proteins involved in biosynthesis of O antigen function in association with the first sugar of the O-specific lipopolysaccharide subunit. Microbiology (2004) 1.36
Gram-negative outer membrane vesicles: beyond the cell surface. Geobiology (2008) 1.35
Lack of cross-protection against diarrhea due to Vibrio cholerae O139 (Bengal strain) after oral immunization of rabbits with V. cholerae O1 vaccine strain CVD103-HgR. J Infect Dis (1994) 1.35
Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera. Infect Immun (2008) 1.32
Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants. Vaccine (2006) 1.31
The toxin-coregulated pilus (TCP) of Vibrio cholerae: molecular cloning of genes involved in pilus biosynthesis and evaluation of TCP as a protective antigen in the infant mouse model. Microb Pathog (1989) 1.29
Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models. Infect Immun (1993) 1.29
The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139. Infect Immun (2004) 1.25
Comparative and genetic analyses of the putative Vibrio cholerae lipopolysaccharide core oligosaccharide biosynthesis (wav) gene cluster. Infect Immun (2002) 1.25
Extracellular nucleases and extracellular DNA play important roles in Vibrio cholerae biofilm formation. Mol Microbiol (2011) 1.25
Serogroup B meningococcal vaccines-an unfinished story. Lancet Infect Dis (2010) 1.20
Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh. J Infect Dis (2005) 1.19
Evaluation of different immunization schedules for oral cholera B subunit-whole cell vaccine in Swedish volunteers. Vaccine (1993) 1.19
Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination. Infect Immun (2005) 1.17
Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls. Infect Immun (1996) 1.17
Lack of cross-protection against diarrhea due to Vibrio cholerae O1 after oral immunization of rabbits with V. cholerae O139 Bengal. J Infect Dis (1994) 1.15
Role of Vibrio cholerae O139 surface polysaccharides in intestinal colonization. Infect Immun (2002) 1.13
Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam. Bull World Health Organ (2002) 1.12
The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers. Infect Immun (2005) 1.12
Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility. Infect Immun (2010) 1.12
Immunological memory after immunization with oral cholera B subunit--whole-cell vaccine in Swedish volunteers. Vaccine (1994) 1.12
Oral vaccines against cholera. Clin Infect Dis (2011) 1.11
An Address on Cholera and its Bacillus. Br Med J (1884) 1.11
Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh. Clin Vaccine Immunol (2012) 1.11
Elucidation of a novel Vibrio cholerae lipid A secondary hydroxy-acyltransferase and its role in innate immune recognition. Mol Microbiol (2011) 1.10
The toxin-coregulated pilus is a colonization factor and protective antigen of Vibrio cholerae El Tor. Microb Pathog (1996) 1.10
Polymyxin B resistance in El Tor Vibrio cholerae requires lipid acylation catalyzed by MsbB. J Bacteriol (2010) 1.09
Molecular and functional characterization of O antigen transfer in Vibrio cholerae. J Biol Chem (2005) 1.08
Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera. Clin Vaccine Immunol (2012) 1.07
Vibrio cholerae flagellins induce Toll-like receptor 5-mediated interleukin-8 production through mitogen-activated protein kinase and NF-kappaB activation. Infect Immun (2008) 1.07
Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines. Vaccine (1990) 1.06
An old enemy returns. Bull World Health Organ (2009) 1.04
Protective immunity induced in mice by detoxified salmonella lipopolysaccharide. J Med Microbiol (1990) 1.03
Novel insight into molecular mechanism of endotoxin shock: biochemical analysis of LPS receptor signaling in a cell-free system targeting NF-kappaB and regulation of cytokine production/action through beta2 integrin in vivo. J Leukoc Biol (1996) 1.01
Vibrio cholerae: lessons for mucosal vaccine design. Expert Rev Vaccines (2011) 1.00
Structural modifications of outer membrane vesicles to refine them as vaccine delivery vehicles. Biochim Biophys Acta (2009) 0.99
Intranasal immunization with nontypeable Haemophilus influenzae outer membrane vesicles induces cross-protective immunity in mice. PLoS One (2012) 0.97
Next-generation outer membrane vesicle vaccines against Neisseria meningitidis based on nontoxic LPS mutants. Hum Vaccin (2011) 0.95
Lipidation of an FlrC-dependent protein is required for enhanced intestinal colonization by Vibrio cholerae. J Bacteriol (2007) 0.91
Immunization of mice with vibrio cholerae outer-membrane vesicles protects against hyperinfectious challenge and blocks transmission. J Infect Dis (2011) 0.90
Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice. Infect Immun (2000) 0.90
Lipopolysaccharide from an Escherichia coli htrB msbB mutant induces high levels of MIP-1 alpha and MIP-1 beta secretion without inducing TNF-alpha and IL-1 beta. J Hum Virol (1999) 0.90
Delivery systems: a vaccine strategy for overcoming mucosal tolerance? Expert Rev Vaccines (2009) 0.90
Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants. Infect Immun (2009) 0.88
A Vibrio cholerae classical TcpA amino acid sequence induces protective antibody that binds an area hypothesized to be important for toxin-coregulated pilus structure. Infect Immun (2004) 0.85
Phase I study of detoxified Escherichia coli J5 lipopolysaccharide (J5dLPS)/group B meningococcal outer membrane protein (OMP) complex vaccine in human subjects. Vaccine (2003) 0.85
Progress towards development of a cholera subunit vaccine. Chem Biodivers (2004) 0.84
Monocyte activation test for pro-inflammatory and pyrogenic contaminants of parenteral drugs: test design and data analysis. J Immunol Methods (2004) 0.82
A new Vibrio cholerae sRNA modulates colonization and affects release of outer membrane vesicles. Mol Microbiol (2008) 1.83
Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase. Cell Metab (2012) 1.71
A common pathway for O-linked protein-glycosylation and synthesis of capsule in Acinetobacter baumannii. Mol Microbiol (2013) 1.65
Adipose triglyceride lipase deficiency causes tissue-specific changes in insulin signaling. J Biol Chem (2009) 1.63
Vibrio cholerae phage K139: complete genome sequence and comparative genomics of related phages. J Bacteriol (2002) 1.53
Role of cyclic Di-GMP during el tor biotype Vibrio cholerae infection: characterization of the in vivo-induced cyclic Di-GMP phosphodiesterase CdpA. Infect Immun (2008) 1.47
Identification of a general O-linked protein glycosylation system in Acinetobacter baumannii and its role in virulence and biofilm formation. PLoS Pathog (2012) 1.41
Transmission of Vibrio cholerae is antagonized by lytic phage and entry into the aquatic environment. PLoS Pathog (2008) 1.34
Comparative and genetic analyses of the putative Vibrio cholerae lipopolysaccharide core oligosaccharide biosynthesis (wav) gene cluster. Infect Immun (2002) 1.25
Extracellular nucleases and extracellular DNA play important roles in Vibrio cholerae biofilm formation. Mol Microbiol (2011) 1.25
Role of Vibrio cholerae O139 surface polysaccharides in intestinal colonization. Infect Immun (2002) 1.13
Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility. Infect Immun (2010) 1.12
A point mutation in the sensor histidine kinase SaeS of Staphylococcus aureus strain Newman alters the response to biocide exposure. J Bacteriol (2009) 1.10
A yeast two-hybrid screen for SYP-3 interactors identifies SYP-4, a component required for synaptonemal complex assembly and chiasma formation in Caenorhabditis elegans meiosis. PLoS Genet (2009) 1.10
CRA-1 uncovers a double-strand break-dependent pathway promoting the assembly of central region proteins on chromosome axes during C. elegans meiosis. PLoS Genet (2008) 1.09
Molecular and functional characterization of O antigen transfer in Vibrio cholerae. J Biol Chem (2005) 1.08
Vibrio cholerae evades neutrophil extracellular traps by the activity of two extracellular nucleases. PLoS Pathog (2013) 1.07
Functional cardiac lipolysis in mice critically depends on comparative gene identification-58. J Biol Chem (2013) 1.00
Porin OmpP2 of Haemophilus influenzae shows specificity for nicotinamide-derived nucleotide substrates. J Biol Chem (2003) 0.99
NAD+ utilization in Pasteurellaceae: simplification of a complex pathway. J Bacteriol (2006) 0.99
Regulation of the chitobiose-phosphotransferase system in Vibrio cholerae. Arch Microbiol (2007) 0.98
Aerobic growth deficient Haemophilus influenzae mutants are non-virulent: implications on metabolism. Int J Med Microbiol (2003) 0.97
Intranasal immunization with nontypeable Haemophilus influenzae outer membrane vesicles induces cross-protective immunity in mice. PLoS One (2012) 0.97
Rapid determination of urinary globotriaosylceramide isoform profiles by electrospray ionization mass spectrometry using stearoyl-d35-globotriaosylceramide as internal standard. Rapid Commun Mass Spectrom (2005) 0.90
Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles. Int J Med Microbiol (2013) 0.89
Tandem mass spectrometric analysis of a complex triterpene saponin mixture of Chenopodium quinoa. J Am Soc Mass Spectrom (2006) 0.89
PnuC and the utilization of the nicotinamide riboside analog 3-aminopyridine in Haemophilus influenzae. Antimicrob Agents Chemother (2004) 0.88
Nicotinamide ribosyl uptake mutants in Haemophilus influenzae. Infect Immun (2003) 0.86
Disulfide bond formation and ToxR activity in Vibrio cholerae. PLoS One (2012) 0.86
Adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) deficiencies affect expression of lipolytic activities in mouse adipose tissues. Mol Cell Proteomics (2012) 0.86
Adipose triglyceride lipase affects triacylglycerol metabolism at brain barriers. J Neurochem (2011) 0.86
Probing the interactions of macrolide antibiotics with membrane-mimetics by NMR spectroscopy. J Med Chem (2012) 0.86
A novel regulatory protein involved in motility of Vibrio cholerae. J Bacteriol (2009) 0.85
Coupling of NAD+ biosynthesis and nicotinamide ribosyl transport: characterization of NadR ribonucleotide kinase mutants of Haemophilus influenzae. J Bacteriol (2005) 0.82
Characterizing lipopolysaccharide and core lipid A mutant O1 and O139 Vibrio cholerae strains for adherence properties on mucus-producing cell line HT29-Rev MTX and virulence in mice. Int J Med Microbiol (2005) 0.82
Can electromagnetic fields influence the structure and enzymatic digest of proteins? A critical evaluation of microwave-assisted proteomics protocols. J Proteomics (2012) 0.82
Lipolytic and esterolytic activity-based profiling of murine liver. Proteomics (2008) 0.82
Characterizing the hexose-6-phosphate transport system of Vibrio cholerae, a utilization system for carbon and phosphate sources. J Bacteriol (2013) 0.82
Functional fat body proteomics and gene targeting reveal in vivo functions of Drosophila melanogaster α-Esterase-7. Insect Biochem Mol Biol (2011) 0.80
Characterization and identification of mycosporines-like compounds in cyanolichens. Isolation of mycosporine hydroxyglutamicol from Nephroma laevigatum Ach. Phytochemistry (2011) 0.79
Enantioselective trace analysis of amphetamine in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry. Rapid Commun Mass Spectrom (2003) 0.78
Transposon insertion in a serine-specific minor tRNA coding sequence affects intraperitoneal survival of Haemophilus influenzae in the infant rat model. Int J Med Microbiol (2009) 0.78
Transposon Tn10. Methods Mol Med (2003) 0.77
Synthetic LXR agonist suppresses endogenous cholesterol biosynthesis and efficiently lowers plasma cholesterol. Curr Pharm Biotechnol (2011) 0.76
Structural and functional implications of the interaction between macrolide antibiotics and bile acids. Chemistry (2015) 0.75
Quantitative trace analysis of estriol in human plasma by negative ion chemical ionization gas chromatography-mass spectrometry using a deuterated internal standard. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 0.75
Synthesis of [(18)O(2)]valproic acid and its use as an internal standard for the quantitative measurement by gas chromatography-electron ionization mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 0.75
Dimer formation upon deprotonation: synthesis and structure of a m-terphenyl substituted (R,S)-dilithium disiloxanolate disilanol. Dalton Trans (2015) 0.75
Cytotoxic furanogermacranolides from the flowers of Helianthus angustifolius. Planta Med (2011) 0.75
Exploring the anion-cation interaction in m-terphenyltetrafluorosilicates by using multinuclear NMR spectroscopy, X-ray diffraction, and ICR-FT-MS. Chemistry (2009) 0.75
Inhibition of NO production by Grindelia argentina and isolation of three new cytotoxic saponins. Chem Biodivers (2014) 0.75